The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...

Intelligent Bio Solutions expects a sixth U.S. patent for its innovative non-invasive drug testing technology, enhancing market entry plans. Intelligent Bio Solutions Inc. (INBS), a medical technology ...

With more than 230,000 positive drug tests since 2020, how the trucking industry detects drivers’ drug use is an important topic. Currently, Department of Transportation drug testing relies entirely ...

The U.S. Food and Drug Administration said on Thursday that it will be phasing out the animal testing requirement for monoclonal antibody therapies and other drugs, replacing it with more ethical ...